HR1843
Senate
119th Congress
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Referred to the House Committee on Energy and Commerce.
Recent Activity
Referred to the House Committee on Energy and Commerce.
3/5/2025IntroReferral
Introduced in House
3/5/2025IntroReferral
Introduced in House
3/5/2025IntroReferral
Viewing 3 of 3 actions
Details
- Introduced
- 3/5/2025
![Rep. Dunn, Neal P. [R-FL-2]](https://unitedstates.github.io/images/congress/original/D000628.jpg)